Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting

Leukemia and Lymphoma

Volumn 48, Issue 6, 2007, Pages 1173-1178

  Malhotra, Pankaj ^a   Varma, Subhash ^a   Varma, Neelam ^a   Kumari, Savita ^a   Das, Reena ^a   Jain, Sanjay ^a   Ahluwalia, Jasmina ^a   Mahi, Sushil ^a   Sharma, Suresh Chander ^a   Radhika, Srinivasan ^b  

^a Department of Internal Medicine ^*  (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Adult acute lymphoblastic leukemia; Developing country; Lymphoid leukemia; Neoplasia; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PROTOCOL; DEATH; FEMALE; FOLLOW UP; HUMAN; INDIA; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; COMBINED MODALITY THERAPY; DAUNORUBICIN; FEMALE; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 34347359633     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701343255     Document Type: Article

References (14)

1. Rowe, J. M., Buck, G., Burnett, A. K., Chopra, R., Wiernik, P. H. and Richards, S. M. (2005) Induction therapy for adults with acute lymphoblastic leukemia: Results of over 1,500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, pp. 3760-3767.
2. Pui, C-H and Evans, W. E. (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med, 354, pp. 166-178.
3. Advani, S., Pai, S., Venzon, D., Adde, M., Kurkure, P. K. and Nair, C. N. (1999) Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen. Ann Oncol, 10, pp. 167-176.
4. Raje, N., Pai, S., Vaidya, S., Gopal, R., Parikh, P. M. and Saikia, T. (1994) Adult acute lymphoblastic leukemia: Results of an aggressive regimen in India. Leuk Lymphoma, 14, pp. 285-290.
5. Magrath, I., Shanta, V. and Advani, S. (2005) Treatment of acute lymphoblastic leukaemia in countries with limited resources: Lessons from use of a single protocol in India over a twenty year period. Eur J Cancer, 41, pp. 1570-1583.
6. Kudva, G. C., Chandy, M., Dennison, D., Srivastava, A. and Bhushan, V. (1994) Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen. Indian J Cancer, 31, pp. 1-7.
7. Bosco, I. and Teh, A. (1995) Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: Comparison with previous multicentre German study. Leukaemia, 9, pp. 951-954.
8. Chim, C. S., Kwong, I YL and Chu, Y. C. (1997) Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary report. Hematol Oncol, 15, pp. 19-26.
9. Metzger, M. L., Howard, S. C., Fu, L. C., Pena, A., Stefan, R. and Hancock, M. L. (2003) Outcome of childhood acute lymphoblastic leukaemia in resource poor countries. Lancet, 362, pp. 706-708.
10. Magrath, I. (2003) Chemotherapy in developing countries - is less better?. Eur J Cancer, 39, pp. 1497-1500.
11. Mostert, S., Sitaresmi, M. N., Gundy, C. M., Sutaryo and Veerman, A JP (2006) Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics, 118, pp. e1600-e1606.
12. Chandy, M. (2006) An approach to the management of leukemia in the developing world. Clin Lab Haematol, 28, pp. 147-153.
13. Hoelzer, D., Thiel, E., Loffler, H., Bodenstein, H., Plaumann, L. and Buchner, T. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, pp. 123-131.
14. Lilleyman, J. (2003) Simple deliverable therapy needed for childhood leukaemia. Lancet, 362, pp. 676-677.